Sonoma Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- 3. Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

5. Derivative Liabilities (Details - Valuation Assumptions)

v2.4.1.9

5. Derivative Liabilities (Details - Valuation Assumptions) (USD $)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Sep. 30, 2014	Mar. 31, 2014
Warrants [Member]
Fair Value Outstanding at end of period	$ 1,697,000	$ 856,000	$ 3,175,000
Placement Agent Warrants [Member]
Warrants	16,500	16,500	16,500
Remaining Contract Term in Years	1 year 10 months 2 days	1 year 7 months 2 days	2 years 1 month 2 days
Exercise Price	$ 5.00	$ 5.00	$ 5.00
Volatility	100.00%	100.00%	128.00%
Risk-free Interest Rate	0.47%	0.58%	0.44%
Fair Value Outstanding at end of period	19,000	11,000	37,000
Investor - Series A Warrants [Member]
Warrants	1,000	1,000	1,000
Remaining Contract Term in Years	1 year 1 month 28 days	10 months 24 days	1 year 4 months 28 days
Exercise Price	$ 3.00	$ 3.00	$ 3.00
Volatility	100.00%	100.00%	128.00%
Risk-free Interest Rate	0.11%	0.13%	0.44%
Fair Value Outstanding at end of period	1,000	1,000	1,000
Investor - Series B Warrants [Member]
Warrants	1,400,000	1,400,000	1,400,000
Remaining Contract Term in Years	1 year 1 month 28 days	10 months 24 days	1 year 4 months 28 days
Exercise Price	$ 3.63	$ 3.63	$ 3.63
Volatility	100.00%	100.00%	128.00%
Risk-free Interest Rate	0.11%	0.13%	0.44%
Fair Value Outstanding at end of period	1,568,000	777,000	2,958,000
Placement Agent Warrants 2 [Member]
Warrants	69,037	69,037	69,037
Remaining Contract Term in Years	1 year 10 months 2 days	1 year 7 months 2 days	2 years 1 month 2 days
Exercise Price	$ 3.00	$ 3.00	$ 3.00
Volatility	100.00%	100.00%	128.00%
Risk-free Interest Rate	0.47%	0.58%	0.44%
Fair Value Outstanding at end of period	$ 109,000	$ 67,000	$ 179,000

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.D.2)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section D

-Subsection 2

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iv)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

+ Details

Name:	us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_AwardTypeAxis=ocls_InvestorSeries1tWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=ocls_InvestorSeries2WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=ocls_PlacementAgentWarrants2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=ocls_PlacementAgentWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: